MACHALA, Miroslav, Jirina PROCHAZKOVA, Jirina HOFMANOVA, Lucie KRALIKOVA, Josef SLAVIK, Zuzana TYLICHOVA, Petra OVESNÁ, Alois KOZUBIK a Jan VONDRACEK. Colon Cancer and Perturbations of the Sphingolipid Metabolism. International Journal of Molecular Sciences. Basel: Multidisciplinary Digital Publishing Institute, 2019, roč. 20, č. 23, s. 1-14. ISSN 1422-0067. Dostupné z: https://dx.doi.org/10.3390/ijms20236051.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Colon Cancer and Perturbations of the Sphingolipid Metabolism
Autoři MACHALA, Miroslav (203 Česká republika, garant), Jirina PROCHAZKOVA (203 Česká republika), Jirina HOFMANOVA (203 Česká republika), Lucie KRALIKOVA (203 Česká republika), Josef SLAVIK (203 Česká republika), Zuzana TYLICHOVA (203 Česká republika), Petra OVESNÁ (203 Česká republika, domácí), Alois KOZUBIK (203 Česká republika) a Jan VONDRACEK (203 Česká republika).
Vydání International Journal of Molecular Sciences, Basel, Multidisciplinary Digital Publishing Institute, 2019, 1422-0067.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 10608 Biochemistry and molecular biology
Stát vydavatele Švýcarsko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 4.556
Kód RIV RIV/00216224:14110/19:00112411
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.3390/ijms20236051
UT WoS 000504428300233
Klíčová slova anglicky colorectal cancer; colon cancer cells; sphingolipid; glycosphingolipid; colon cancer (CRC) sphingolipidomics; sphingosine-1-phosphate; lactosylceramide
Štítky 14119612, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 21. 7. 2021 10:30.
Anotace
The development and progression of colorectal cancer (CRC), a major cause of cancer-related death in the western world, is accompanied with alterations of sphingolipid (SL) composition in colon tumors. A number of enzymes involved in the SL metabolism have been found to be deregulated in human colon tumors, in experimental rodent studies, and in human colon cancer cells in vitro. Therefore, the enzymatic pathways that modulate SL levels have received a significant attention, due to their possible contribution to CRC development, or as potential therapeutic targets. Many of these enzymes are associated with an increased sphingosine-1-phosphate/ceramide ratio, which is in turn linked with increased colon cancer cell survival, proliferation and cancer progression. Nevertheless, more attention should also be paid to the more complex SLs, including specific glycosphingolipids, such as lactosylceramides, which can be also deregulated during CRC development. In this review, we focus on the potential roles of individual SLs/SL metabolism enzymes in colon cancer, as well as on the pros and cons of employing the current in vitro models of colon cancer cells for lipidomic studies investigating the SL metabolism in CRC.
VytisknoutZobrazeno: 13. 7. 2024 13:59